PMC:7105881 / 1152-1582 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"55","span":{"begin":69,"end":77},"obj":"Species"},{"id":"56","span":{"begin":82,"end":90},"obj":"Species"},{"id":"57","span":{"begin":134,"end":140},"obj":"Species"},{"id":"58","span":{"begin":231,"end":236},"obj":"Species"},{"id":"59","span":{"begin":237,"end":241},"obj":"Species"},{"id":"60","span":{"begin":304,"end":312},"obj":"Species"},{"id":"61","span":{"begin":317,"end":325},"obj":"Species"},{"id":"62","span":{"begin":407,"end":412},"obj":"Species"},{"id":"63","span":{"begin":413,"end":417},"obj":"Species"},{"id":"73","span":{"begin":55,"end":65},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"Tax:694009"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"Tax:1335626"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:9606"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:11118"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:694009"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Tax:1335626"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Tax:9606"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Tax:11118"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":210,"end":218},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":55,"end":65},"obj":"Disease"},{"id":"T10","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"T11","span":{"begin":304,"end":312},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":5,"end":6},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T11","span":{"begin":105,"end":108},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T12","span":{"begin":134,"end":140},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T13","span":{"begin":231,"end":236},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T14","span":{"begin":407,"end":412},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":210,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":142,"end":418},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T27","span":{"begin":69,"end":77},"obj":"SP_10"},{"id":"T28","span":{"begin":82,"end":90},"obj":"SP_9"},{"id":"T29","span":{"begin":134,"end":140},"obj":"NCBITaxon:9606"},{"id":"T30","span":{"begin":231,"end":236},"obj":"SP_6;NCBITaxon:9606"},{"id":"T31","span":{"begin":304,"end":312},"obj":"SP_10"},{"id":"T32","span":{"begin":317,"end":325},"obj":"SP_9"},{"id":"T33","span":{"begin":407,"end":412},"obj":"SP_6;NCBITaxon:9606"},{"id":"T89984","span":{"begin":69,"end":77},"obj":"SP_10"},{"id":"T56264","span":{"begin":82,"end":90},"obj":"SP_9"},{"id":"T11552","span":{"begin":134,"end":140},"obj":"NCBITaxon:9606"},{"id":"T28582","span":{"begin":231,"end":236},"obj":"SP_6;NCBITaxon:9606"},{"id":"T48545","span":{"begin":304,"end":312},"obj":"SP_10"},{"id":"T62193","span":{"begin":317,"end":325},"obj":"SP_9"},{"id":"T56881","span":{"begin":407,"end":412},"obj":"SP_6;NCBITaxon:9606"}],"text":"ough a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subun"}